Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
72.2M
-
Shares change
-
-798K
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
-$7.63M
-
Put/Call ratio
-
0.67
-
Number of buys
-
84
-
Number of sells
-
-62
-
Price
-
$19.57
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2019
179 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2019.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.2M shares
of 114M outstanding shares and own 63.15% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (11.2M shares), FMR LLC (6.89M shares), BlackRock Inc. (5.79M shares), VICTORY CAPITAL MANAGEMENT INC (4.23M shares), VANGUARD GROUP INC (3.12M shares), Casdin Capital, LLC (2.55M shares), STATE STREET CORP (2.38M shares), Grosvenor Holdings, L.L.C. (2.29M shares), FARALLON CAPITAL MANAGEMENT LLC (2.25M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.